Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder

Yasar Tanir| Gaye Turkmen

2020, Vol: 30, Issue: 4

30/4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

PCP_Copyright_Transfer_Form

« Previous Article

Case Report

Psychiatry and Clinical Psychopharmacology - PCP. 2020; 30(4): 464-466

doi: 10.5455/PCP.20201009072139

Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder

Yasar Tanir, Gaye Turkmen.

Abstract
Atomoxetine, a selective norepinephrine (noradrenaline) reuptake inhibitor, is an effective and safe medication in the treatment of attention-deficit hyperactivity disorder (ADHD) with or without autism spectrum disorder (ASD) in children. However, unusual side effects may occur during the course of the treatment. In this case study, we present a 6-year-old child diagnosed with ASD comorbid with ADHD who developed atomoxetine induced mania during his treatment for ADHD.

Key words: Atomoxetine, Mania, Autism Spectrum Disorder

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Yasar Tanir Articles by Gaye Turkmen
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Tanir Y, Turkmen G. Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology - PCP. 2020; 30(4): 464-466. doi:10.5455/PCP.20201009072139

Web Style

Tanir Y, Turkmen G. Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. http://www.psychiatryandclinicalpsychopharmacology.org/?mno=7863 [Access: December 28, 2020]. doi:10.5455/PCP.20201009072139

AMA (American Medical Association) Style

Tanir Y, Turkmen G. Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology - PCP. 2020; 30(4): 464-466. doi:10.5455/PCP.20201009072139

Vancouver/ICMJE Style

Tanir Y, Turkmen G. Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology - PCP. (2020), [cited December 28, 2020]; 30(4): 464-466. doi:10.5455/PCP.20201009072139

Harvard Style

Tanir, Y. & Turkmen, . G. (2020) Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology - PCP, 30 (4), 464-466. doi:10.5455/PCP.20201009072139

Turabian Style

Tanir, Yasar, and Gaye Turkmen. 2020. Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology, 30 (4), 464-466. doi:10.5455/PCP.20201009072139

Chicago Style

Tanir, Yasar, and Gaye Turkmen. "Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder." Psychiatry and Clinical Psychopharmacology 30 (2020), 464-466. doi:10.5455/PCP.20201009072139

MLA (The Modern Language Association) Style

Tanir, Yasar, and Gaye Turkmen. "Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder." Psychiatry and Clinical Psychopharmacology 30.4 (2020), 464-466. Print. doi:10.5455/PCP.20201009072139

APA (American Psychological Association) Style

Tanir, Y. & Turkmen, . G. (2020) Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology, 30 (4), 464-466. doi:10.5455/PCP.20201009072139

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights) Privacy Policy Publication Ethics and Publication Malpractice Statement Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information



Copyright © 2021 Psychiatry and Clinical Psychopharmacology All Rights Reserved. Subject to change without notice from or liability to Psychiatry and Clinical Psychopharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Editorial Correspondence Prof. Dr. Mesut ÇETİN Bagdat Cad. Birgen Is Merkezi 226/7 Kadikoy - Istanbul - TURKEY 34728 Mobile: +90 (532) 272 32 52 Email: psikofarmakoloji@gmail.com Publisher Prof. Dr. Mesut Cetin Bagdat Cad. Birgen Is Merkezi 226/7 Kadikoy - Istanbul - TURKEY 34728 Mobile: +90 (532) 272 32 52 Email: psikofarmakoloji@gmail.com

Contact Information

How to cite this article